LRRC4 expression was also reduced in serous ovarian cancer cells with ascitic cytology-positive patients (Figure 1C), suggesting that low expression of LRRC4 is associated with high-degree EOC malignant progression and metastasis. Here, LRRC4 is linked to ovarian serous adenocarcinoma.